What question did this study set out to answer?

The aim is to investigate the effects of Limosilactobacillus fermentum 50 on vulvovaginal candidiasis and its potential mechanisms.

April 3, 2026

Limosilactobacillus fermentum 50 Alleviates Vulvovaginal Candidiasis via the Gut-Vagina Axis: Modulating Microbiota, Barrier Function and Inflammation

XBXi BaiChina Agricultural University ZCZhichao ChenChina Agricultural University YJYizhi JingMinistry of Education

Key Points

The aim is to investigate the effects of Limosilactobacillus fermentum 50 on vulvovaginal candidiasis and its potential mechanisms.
Evaluated the growth-inhibitory activity of Limosilactobacillus fermentum 50 against candida species
Analyzed changes in vaginal microbiota composition pre- and post-intervention
Measured inflammatory markers and barrier function in the vaginal environment
Limosilactobacillus fermentum 50 significantly reduced candida growth
Restoration of healthy vaginal microbiota was observed
Inflammatory markers decreased, indicating reduced inflammation

Abstract

Vulvovaginal candidiasis (VVC) is a common vaginal disease characterized by inflammatory cell infiltration and vaginal microbiota dysbiosis. In this study, Limosilactobacillus fermentum 50 not only exhibited the strongest growth-inhibitory activity...

Perguntar à IA

Bookmark

View Full Paper